Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03368963
Title TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Emory University
Indications

pancreatic adenocarcinoma

colorectal adenocarcinoma

cholangiocarcinoma

gastric adenocarcinoma

Therapies

MM-398 + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.